Skip to main navigation Skip to search Skip to main content

Investigating the mode of action of ACB1801 on increasing TAP1 and improving cancer immunotherapy

Project Details

AcronymINCEPTOR
StatusFinished
Effective start/end date1/04/2431/03/26

Funding

  • European Commission: €191,760.00